1 |
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab |
Adalimumab |
[5] D02597 D02597, D02598 D02598, D04358 D04358, D08083 D08083, D09214 D09214 💬 |
IL12A [6] IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
2 |
Mln0002 (vedolizumab) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
3 |
Vedolizumab |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
4 |
Vedolizumab (genetical recombination) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
5 |
Vedolizumab 108 mg sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
6 |
Vedolizumab 300 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
7 |
Vedolizumab 300 mg injection [entyvio] |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
8 |
Vedolizumab 300 mg iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
9 |
Vedolizumab injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
10 |
Vedolizumab intravenous (iv), vedolizumab subcutaneous (sc), placebo iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
11 |
Vedolizumab intravenous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
12 |
Vedolizumab iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
13 |
Vedolizumab iv (entyvio™) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
14 |
Vedolizumab iv 300 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |
15 |
Vedolizumab iv, placebo iv, placebo sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
16 |
Vedolizumab iv, placebo sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
17 |
Vedolizumab sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
18 |
Vedolizumab sc 108 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
19 |
Vedolizumab subcutaneous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
20 |
Vedolizumab-800cw |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [1] 96 💬 |